Supply Chain Models for Global Trials: Singapore as the APAC Gateway to the World

Supply Chain Models for Global Trials: Singapore as the APAC Gateway to the World

With an increasing number of clinical studies being conducted in the Asia-Pacific (APAC) region, there is a growing need for streamlining import and export strategies and clinical supply support. Multiple factors, including positive changes in clinical research regulations, reduced costs to run trials, and large urban-centered populations are attracting sponsors to the region. Register for this webcast to get expert insights on using Singapore as a clinical supply hub.

#ccpeventcalendar, #SupplyChain, #GlobalSupply, #2020events


News Feed

Follow CCP